Lemonade, Inc. (NYSE:LMND – Get Free Report) shares rose 9% during trading on Monday after Keefe, Bruyette & Woods raised their price target on the stock from $35.00 to $40.00. Keefe, Bruyette & Woods currently has an underperform rating on the stock. Lemonade traded as high as $73.21 and last traded at $73.4010. Approximately 370,655 shares were traded during trading, a decline of 85% from the average daily volume of 2,437,055 shares. The stock had previously closed at $67.35.
A number of other equities analysts have also issued reports on the stock. BMO Capital Markets raised their target price on shares of Lemonade from $23.00 to $42.00 and gave the stock an “underperform” rating in a research report on Monday, August 18th. Citigroup reiterated a “market outperform” rating on shares of Lemonade in a research note on Monday. Weiss Ratings restated a “sell (d-)” rating on shares of Lemonade in a research note on Wednesday, October 8th. JMP Securities set a $80.00 target price on shares of Lemonade in a report on Monday. Finally, Cantor Fitzgerald raised Lemonade to a “strong-buy” rating in a report on Wednesday, August 13th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $58.57.
View Our Latest Stock Report on Lemonade
Insider Activity at Lemonade
Hedge Funds Weigh In On Lemonade
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. CIBC Bancorp USA Inc. purchased a new position in shares of Lemonade in the 3rd quarter valued at about $318,000. Advisory Services Network LLC acquired a new position in Lemonade during the third quarter worth about $216,000. CANADA LIFE ASSURANCE Co grew its position in Lemonade by 11.6% during the third quarter. CANADA LIFE ASSURANCE Co now owns 17,769 shares of the company’s stock worth $966,000 after buying an additional 1,844 shares during the period. Worth Venture Partners LLC purchased a new position in Lemonade in the third quarter valued at about $297,000. Finally, PharVision Advisers LLC acquired a new stake in shares of Lemonade during the 3rd quarter valued at approximately $214,000. 80.30% of the stock is owned by institutional investors and hedge funds.
Lemonade Stock Performance
The stock’s 50-day moving average price is $59.96 and its 200-day moving average price is $49.24. The company has a market capitalization of $5.54 billion, a price-to-earnings ratio of -31.01 and a beta of 2.27.
Lemonade (NYSE:LMND – Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. The company reported ($0.51) earnings per share for the quarter, beating the consensus estimate of ($0.72) by $0.21. The firm had revenue of $194.50 million during the quarter, compared to the consensus estimate of $185.06 million. Lemonade had a negative return on equity of 31.86% and a negative net margin of 26.39%.Lemonade’s quarterly revenue was up 42.4% on a year-over-year basis. During the same period last year, the business posted ($0.95) EPS. Lemonade has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. Analysts anticipate that Lemonade, Inc. will post -3.03 earnings per share for the current year.
About Lemonade
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Featured Articles
- Five stocks we like better than Lemonade
- How to invest in marijuana stocks in 7 steps
- Warner Bros. Sale Rumors Heat Up: What Investors Need to Know
- 3 Healthcare Dividend Stocks to Buy
- From Science Project to Solvent: WeRide’s 761% Revenue Surge
- 3 Dividend Kings To Consider
- Will the S&P 500 Rally in December? These 3 Signals Point to a Big Move Ahead
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.
